New ipratropium formulation to decrease nebulization time

Respiratory Medicine

Volumn 101, Issue 2, 2007, Pages 237-245

  Majoral, Caroline ^a,b,c   Vecellio, Laurent ^a,b,c   Grimbert, Daniel ^a,b,c   de Monte, Michèle ^a,b,c   le Guellec, Chantal ^d   Ingremeau, Valérie ^d   Minois, Carole ^c   Cordeau, Emeline ^c   Paintaud, Gilles ^d   Steinberg, Anouck ^e   Diot, Patrice ^a,b,c  

^a INSERM   (France)

^b IFR 135   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d CHU BRETONNEAU   (France)

^e BOEHRINGER INGELHEIM   (France)

Author keywords

Aerosol; Anticholinergic; Ipratropium bromide; Jet nebulizer; Nebulization time; Terbutaline

Indexed keywords

IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS TERBUTALINE; TERBUTALINE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MIXTURE; MEDICAL NEBULIZER; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AEROSOLS; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; EQUIPMENT DESIGN; HUMANS; IPRATROPIUM; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; SPECTROPHOTOMETRY, ULTRAVIOLET; TERBUTALINE; TIME FACTORS;

EID: 33846159466     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.05.015     Document Type: Article

References (17)

1. Dolovich M.B., MacIntyre N.R., Anderson P.J., et al. Consensus statement: aerosols and delivery devices. J Aerosol Med 13 (2000) 291-300
2. Dalby R.N., Tiano S.L., and Hickey A.J. Medical devices for the delivery of therapeutic aerosols to the lungs. In: Hickey A.J. (Ed). Inhalation aerosols-physical and biological basis for therapy (lung biology in health and disease-volume 94). Executive Editor: Claude Lenfant (1996), Marcel Dekker, Inc., New York
3. Smaldone G.C. Drug delivery via aerosol systems: concept of "aerosol inhaled". J Aerosol Med 4 (1991) 229-235
4. Morrow P.E. Conference on the scientific basis of respiratory therapy. Aerosol therapy. Aerosol characterization and deposition. Am Rev Respir Dis 110 (1974) 88-99
5. Alvine G.F., Rodgers P., Fitzsimmons K.M., and Ahrens R.C. Disposable nebulizers: how reliable are they?. Chest 101 (1992) 316-319
6. EN 13544-1. Respiratory therapy equipment-Part 1: Nebulising systems and their components. Official Journal of the European Union 2001.
7. De Boer A.H., Gjaltema D., Hagedoorn P., and Frijlink H.W. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int J Pharm 249 (2002) 219-231
8. Clark A.R. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 115 (1995) 69-78
9. Merkus H.G., Marijnissen J.C.M., Jansma H.L., and Scarlett B. Droplet size distribution measurements for medical nebulizers by the forward light scattering technique ("Laser Diffraction"). J Aerosol Sci 25 (1994) S319-S320
10. Corcoran T.E., Hitron R., Humphrey W., and Chigier N. Optical measurement of nebulizer sprays: a quantitative comparison of diffraction Phase Doppler Interferometry, and Time of Flight techniques. J Aerosol Sci 31 (2000) 35-50
11. Vecellio None L., Chantrel G., Grimbert D., De Monte M., and Diot P. Influence of drug physico chemical characteristics on the performances of a new single use jet nebulizer. The aerosol society, DDL 14 (drug delivery to the lungs XIV) (2003) 98-101
12. Lemarié E., and Diot P. Adrenergic beta agonists and anticholinergics in obstructive lung diseases. J Aerosol Med 10 (1997) 75-83
13. Greenough A., Yuksel B., Everett L., and Price J.F. Inhaled ipratropium bromide and terbutaline in asthmatic children. Respir Med 87 (1993) 111-114
14. Ikeda A., Nishimura K., Koyama H., and Izumi T. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. Chest 107 (1995) 401-405
15. Boe J., Dennis J.H., O'Driscoll B.R., et al. European respiratory society guidelines on the use of nebulizers. Eur Respir J 18 (2001) 228-242
16. Fink J.B., and Simmons R. Does reduced dose volume impact inhaled mass with a novel residual volume nebulizer?. Eur Respir Soc Annu Congr (2003)
17. Rodrigo G.J., and Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 122 (2002) 60-165